Aethlon Medical Aktie [WKN DE: A14RTU / ISIN: US00808Y2081]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Aethlon Medical Inc

10.05.24		Aethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial Results (RTTNews)
21.02.24		Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices (RTTNews)
14.11.23		Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
13.11.23		Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (PR Newswire)
06.11.23		Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 (PR Newswire)
10.10.23		Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology (PR Newswire)
04.10.23		Aethlon Announces Reverse Stock Split (PR Newswire)
30.08.23		Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire)
10.08.23		Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update (PR Newswire)
03.08.23		Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 (PR Newswire)
24.07.23		Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant (PR Newswire)
06.07.23		Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors (PR Newswire)
28.06.23		Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire)
22.06.23		Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023 (PR Newswire)
21.06.23		Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation (PR Newswire)
14.06.23		Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest (PR Newswire)
01.06.23		Aethlon Medical to Present at the 13th Annual LD Micro Invitational (PR Newswire)
22.05.23		Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India (PR Newswire)
13.02.23		Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
31.01.23		Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023 (PR Newswire)
30.01.23		Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer (PR Newswire)
14.11.22		Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
02.11.22		Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022 (PR Newswire)
06.09.22		Aethlon Medical to Present at Two Investor Conferences in September (PR Newswire)
09.08.22		Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update (PR Newswire)
03.08.22		Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022 (PR Newswire)
28.07.22		Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants (PR Newswire)
11.07.22		FDA Approves Aethlon Medical's Protocol Amendment For COVID-19 Trial (RTTNews)
11.07.22		Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment (PR Newswire)
28.06.22		Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire)
21.06.22		Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022 (PR Newswire)
17.05.22		Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference (PR Newswire)
02.05.22		Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants (PR Newswire)
28.03.22		Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors (PR Newswire)
14.02.22		Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
31.01.22		Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022 (PR Newswire)
09.11.21		Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
02.11.21		Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021 (PR Newswire)
12.10.21		Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier® (PR Newswire)
30.09.21		Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs (PR Newswire)
09.09.21		Pre-market Movers: HGEN, PMCB, CRDF, HLBZ, LULU… (RTTNews)
07.09.21		Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
04.01.21		Pre-market Movers In Healthcare Sector: OCGN, BNGO, JAGX, IMMP, SLLS… (RTTNews)
16.12.20		Stock Alert: Aethlon Medical Jumps 45% (RTTNews)
14.10.20		LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
19.06.20		FDA Nod For EPZM, RARE, Court Rules In MYL's Favor, Ocuphire To Hop Onto Nasdaq, ALPN Soars (RTTNews)
18.06.20		Stock Alert: Aethlon Medical Surges After FDA Okays Hemopurifier Testing For COVID-19 (RTTNews)
18.06.20		Aethlon Medical: FDA Allows Testing Of Hemopurifier In COVID-19; Shares Surge (RTTNews)
28.11.18		ASNS Turning Heads, SPHS To Report Data In Dec., Mark Your Calendar For COCP (RTTNews)
08.06.18		Aethlon Medical Announces Fiscal 2018 Results (PR Newswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

voestalpine-Aktie mit Verlusten: Stabile Erdgasversorgung trotz möglicher Unterbrechungen aus Russland

NVIDIA vor Q3-Ergebnissen: Hohe Erwartungen und höhere Kursziele für den KI-Giganten

Solana noch in diesem Jahr bei 300 US-Dollar?

UN-Klimagipfel in Baku: Baerbock warnt vor 'Killerstürmen'

Angespannte Stimmung in Frankfurt: LUS-DAX gibt am Nachmittag nach

BlackRocks Bitcoin-ETF überholt Gold-ETF

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	22.11.2024 16:21
Kaufwert:	EUR
	Hinzufügen Speichern